ONL1204

· ONL Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ONL1204, covering 2024-09-24 to 2025-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD [Phase 2]